Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 5—October 2000

Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan

Cheng-Hsun Chiu*Comments to Author , Michael Waddingdon†, Wu-Shiun Hsieh*, David E. Greenberg‡, Paul C. Schreckenberger§, and Amy M. Carnahan¶
Author affiliations: *Chang Gung Children's Hospital, Taoyuan, Taiwan; †Accugenix, Inc., Newark, Delaware; ‡British Columbia's Children's Hospital, Vancouver, British Columbia, Canada; §University of Illinois at Chicago Medical Center, Chicago, Illinois, USA; ¶University of Maryland School of Medicine, Baltimore, Maryland, USA

Main Article

Table 2

Comparative in vitro activity of various antibiotics against 17 strains of atypical Chryseobacterium meningosepticum

MIC (µg/mL)
Antibiotics Range MIC50 MIC90
Ampicillin 16-64 32 32
Ticarcillin 32->128 128 >128
Piperacillin 1-128 8 32
Cephalothin 32->32 32 32
Cefamandole 16->32 >32 >32
Cefotaxime 8->32 32 >32
Ceftriaxone 8->32 16 32
Imipenem 1->32 32 32
Ceftazidime 2-64 16 >32
Gentamicin 16-64 32 64
Amikacin 2-64 64 64
Ciprofloxacin 0.25-16 1 4

Main Article

Page created: December 17, 2010
Page updated: December 17, 2010
Page reviewed: December 17, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.